Quick Answer
OptimizeRx Corp reported Total Assets of $176.92 million for fiscal year 2025.
OptimizeRx Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $176.92M | +3.4% |
| 2024 | $171.17M | -6.7% |
| 2023 | $183.37M | +36.2% |
| 2022 | $134.65M | -4.5% |
| 2021 | $140.99M | +133.7% |
| 2020 | $60.33M | +6.5% |
| 2019 | $56.64M | +126.1% |
| 2018 | $25.05M | +156.6% |
| 2017 | $9.76M | -14.9% |
| 2016 | $11.48M | -6.8% |
| 2015 | $12.31M | +75.2% |
| 2014 | $7.03M | +77.8% |
| 2013 | $3.95M | +81.7% |
| 2012 | $2.18M | -24.8% |
| 2011 | $2.89M | -22.8% |
| 2010 | $3.75M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $170.32M | +3.1% | +0.6% |
| June 30, 2025 | $169.26M | -2.1% | +0.9% |
| March 31, 2025 | $167.77M | -4.9% | -2.0% |
| December 31, 2024 | $171.17M | -6.7% | +3.6% |
| September 30, 2024 | $165.20M | +33.3% | -4.4% |
| June 30, 2024 | $172.88M | +42.5% | -2.0% |
| March 31, 2024 | $176.37M | +33.9% | -3.8% |
| December 31, 2023 | $183.37M | +36.2% | +48.0% |
- OptimizeRx Corp showed an increase of +3.4% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, OptimizeRx Corp’s total assets has grown by 4619.5% (from $3.75 million to $176.92 million).
- The most recent figure is from OptimizeRx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: